s6y

425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filed
Accession number
0000950135-06-003276

Documents

  1. EPIX PHARMACEUTICALS, INC. 425
  2. EX-99.1 PRESS RELEASE DATED MAY 5, 2006 EX-99.1
  3. EX-99.2 CONSULTING AGREEMENT BY AND BETWEEN EPIX AND MICHAEL J. ASTRUE, DATED MA EX-99.2

On sec.gov